Navigation Links
Pharmasset Reports Fiscal Second Quarter 2011 Financial Results
Date:4/25/2011

d Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.PHARMASSET, INC.CONDENSED STATEMENTS OF OPERATIONS(UNAUDITED)(in thousands, except share and per share amounts)Three Months EndedMarch 31,20112010Revenues

$
247$
251COSTS AND EXPENSES:  Research and development

16,99512,028  General and administrative

3,7733,647Total costs and expenses

20,76815,675Operating loss

(20,521)(15,424)Investment income

11Other income

--Interest expense

(310)(638)Loss before income taxes

(20,830)(16,061)Provision (benefit) for income taxes

(973)-Net loss

$
(19,857)$
(16,061)Net loss per share: basic and diluted

$
(0.55)$
(0.54)Weighed average shares outstanding:basic and diluted

36,293,89829,522,630PHARMASSET, INC.BALANCE SHEETS(in thousands, except par value, share and per share amounts)As ofAs ofMarch 31,September 30,20112010(unaudited)ASSETSCURRENT ASSETS:  Cash and cash equivalents

$ 208,317

$ 127,081  Amounts due from collaboration partner

-

6  Prepaid expenses and other current assets

856

718Total current assets

209,173

127,805EQUIPMENT AND LEASEHOLD IMPROVEMENTS:  Equipment

4,704

4,060  Leasehold improvements

1,837

1,8376,541

5,897  Less accumulated depreciation and amortization

(4,465)

(4,184)Total equipment and leasehold improvements, net

2,076

1,713Restricted cash

100

100Other assets

140

143Total

$ 211,489

$ 129,761LIABILITIES AND STOCKHOLDERS’ EQUITYCURRENT LIABILITIES:  Current portion of long-term debt

$
,081

$
8,705  Accounts payable

4,163

5,037  Accrued expenses

5,775

5,863  De
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Unichem Pharmaceuticals ( ... one lot of Hydrochlorothiazide tablets 25 mg 1000-count bottle ... as a precautionary measure due to the identification of ... product. The risk associated with mistakenly ... is the increased probability of experiencing Clopidogrel,s side effects ...
(Date:7/30/2015)... Calif. , July 30, 2015  Amgen (NASDAQ: ... , partner and managing director of Warburg Pincus LLC, to ... pleased to welcome Fred Hassan and the deep, ... Amgen Board," said Robert A. Bradway , chairman and ... commitment to innovation will serve Amgen well." Mr. ...
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Regado Biosciences, Inc.,  a privately held company leading ... that Chris Rusconi , PhD, Senior Vice President, Chief ... Vice President , Chief Medical Officer presented an abstract at ... 2010 in Atlanta, Georgia .   The poster, ...
... CINCINNATI , March 15 Kendle ... research organization, today announced its affiliate in China ... obtained ISO 9001:2008 certification from the International Organization for ... in this growing region.  Through KendleWits, Kendle is the ...
Cached Medicine Technology:Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 2Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 4Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 2Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 3Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 4Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate 5
(Date:8/2/2015)... Clarkston, Metamora Michigan (PRWEB) , ... ... ... Organ Prolapse (POP) results when the supportive muscles and connective tissues of ... Causes of this weakness and damage include straining, heavy lifting, obesity, constipation, ...
(Date:8/1/2015)... ... August 02, 2015 , ... Back packs can be dangerous? ... however, back packs can wreck havoc on a kid's spine. With school starting again, ... and from school. Make sure you are aware of how to help them prevent ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are enlarged ... women often causing pain and discomfort. Those who spend a lot of time on ... Houston Vein Center is doing what it can to create awareness and provide a ...
(Date:8/1/2015)... ... 01, 2015 , ... Brig and Lita Hart, icons of the network marketing ... Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been a ... have agreed to join their missions of purpose together to change the course of ...
(Date:8/1/2015)... ... , ... Lume Wellness creators Alex, Robert, and Sam have announced update 3.0.1 ... , The app is designed to track various metrics of wellness, including physical ... personal health and use this information for positive behavior modification. Lume Wellness keeps track ...
Breaking Medicine News(10 mins):Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2
... over the last 25 years according to a report published by ... the UK shows a fall in the presence of harmful heavy ... breathe. , Results show a 70% reduction in the average ... average concentration has fallen from 1873 nanograms per cubic metre of ...
... Lifesciences,Corporation (NYSE: EW ), a world leader ... announced today that it has,completed the sale of ... to C.R. Bard, consistent with the terms previously ... a leader in advanced cardiovascular disease,treatments, is the ...
... SOLANA BEACH, Calif., Jan. 14 Fusion Energy,Products, manufacturer ... owned,subsidiary of Bond Laboratories, Inc. (OTC Bulletin Board: BNLB), ... will be joining its,sponsorship commitment to L&M Racing,s Supercross ... of Fusion Energy Products., "BP and am/pm have ...
... for the first time that the brain processes aggression ... drugs - offering insights into our propensity to fight ... football. , The research will be published online the ... Aggression occurs among virtually all vertebrates and is necessary ...
... Assurant Health, a Milwaukee,WI-based national provider of individual ... today it entered into an agreement,that gives its ... and physicians., Under the agreement Assurant Health ... network, which will expand access to medical,facilities in ...
... Routing cue works like a Zip code helps deliver mail, ... researchers have found a way to modify the surface of ... advance that may prove useful in many areas of stem ... at Brigham and Women,s Hospital in Boston modified the surface ...
Cached Medicine News:Health News:Heavy metal slips down UK air quality charts 2Health News:Fusion Energy Teams Up With BP's 'am/pm' Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution 2Health News:Aggression as rewarding as sex, food and drugs 2Health News:Assurant Health Gains Access to Great-West Healthcare's Nationwide Network 2Health News:Assurant Health Gains Access to Great-West Healthcare's Nationwide Network 3Health News:Stem Cells Modified to Home in Where They're Needed 2
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
... Bactiseal EVD Catheter system ... impregnated catheter for external CSF ... bacteria on catheter tube surfaces. ... Advanced Impregnation Process, it reduces ...
Cruchfield Skull Traction Tong, small pattern....
14 cm - 5 1/2, 6.0 mm , for drill handles and hand drills....
Medicine Products: